IP Library Granted Patent US 9,422,334
Granted Patent B2
US 9,422,334 · App. 13/975,703 · Granted Aug 23, 2016

Plant-derived elastin binding protein ligands and methods of using the same

Inventors: Felipe Jimenez (Seal Beach, CA); Thomas Mitts (Visalia, CA); Aleksander Hinek (Toronto, CA)
Assignees: The Hospital For Sick Children; Human Matrix Sciences, LLC
C07K7/06C07K7/08A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,422,334
App. No.
13/975,703
Granted
Aug 23, 2016
Kind
B2
Abstract

The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.

Claims (10)

1. A synthetic sextapeptide comprising a sequence of IGVAPG (SEQ ID NO: 13).

2. The synthetic sextapeptide of claim 1 , wherein the sextapeptide provides an appearance of increased elastogenesis in a tissue.

3. The synthetic sextapeptide of claim 1 , wherein the sextapeptide stimulates elastogenesis.

4. A method of stimulating elastogenesis comprising administering a therapeutically effective amount of a composition comprising a synthetic peptide having a sequence selected from VGVAPGAAAAAVGVAPG (SEQ ID NO: 10), IGVAPG (SEQ ID NO: 13), and IGVAPGAAAAAIGVAPG (SEQ ID NO: 14).

5. The method of claim 4 , wherein the composition provides an appearance of increased elastogenesis in a tissue.

6. The method of claim 4 , wherein the composition stimulates proliferation and migration of dermal fibroblasts into an area of skin.

7. The method of claim 4 , wherein the composition provides an enhanced deposition of elastin in a tissue.

8. The method of claim 4 , wherein the composition improves the appearance of skin.

9. The method of claim 4 , wherein the administering includes at least one of topical application and application via a transdermal patch.

10. A method of stimulating elastogenesis comprising administering a therapeutically effective amount of a composition comprising a synthetic sextapeptide having a sequence of IGVAPG (SEQ ID NO: 13).

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: ELASTOGENESIS LLC
To: NULASTIN, INC.
Reel/Frame 068190/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2024
From: THE HOSPITAL FOR SICK CHILDREN
To: ELASTOGENESIS LLC
Reel/Frame 067829/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: HUMAN MATRIX SCIENCES, LLC
To: ELASTOGENESIS, LLC
Reel/Frame 048891/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2017
From: MITTS, THOMAS F.; JIMENEZ, FELIPE
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 044470/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2017
From: HINEK, ALEKSANDER
To: THE HOSPITAL FOR SICK CHILDREN
Reel/Frame 044470/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2013
From: MITTS, THOMAS F.; JIMENEZ, FELIPE
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 031081/0577 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2013
From: HINEK, ALEKSANDER
To: THE HOSPITAL FOR SICK CHILDREN
Reel/Frame 031081/0652 →
Continuity (5)
Continuation 12781710 · May 17, 2010
Continuation 11405843 · Apr 17, 2006
Provisional Application 60671557 · Apr 15, 2005
Provisional Application 60737586 · Nov 17, 2005
Related Publication 20140100170A1 · Apr 10, 2014